Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2020-03-17 Major Shareholding Noti…
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2020
Major Shareholding Notification Classification · 1% confidence The document explicitly details a change in shareholding ('Holder: Swedbank Robur Fonder AB') for the issuer CellaVision AB. It quantifies the shares held before and after a transaction, specifies the 'Reason for major shareholding notification Sell', and reports the resulting percentage of voting rights (4.62%). This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2020-03-17 English
Major Shareholding Notification 2020
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding for CellaVision AB, specifically noting the 'Reason for major shareholding notification Buy' and providing 'Before the transaction' and 'After the transaction' figures for shares and voting rights. The structure, focusing on crossing a threshold (10% limit mentioned), clearly indicates a notification regarding a significant change in ownership. This aligns directly with the definition of Major Shareholding Notification (MRQ). The document length is short (3489 chars), but the content is the notification itself, not an announcement of a report.
2020-02-12 English
Earnings Release 2019
Earnings Release Classification · 1% confidence The document is titled "Bokslutskommuniké Jan-dec 2019" (Year-end Report Communication Jan-Dec 2019) and contains detailed financial tables comparing Q4 2019 results against Q4 2018, as well as full-year 2019 results against 2018. It includes key performance indicators like Net Sales, EBITDA, margins, cash flow, and a CEO commentary discussing the full year and the acquisition of RAL Diagnostics. This structure—a comprehensive summary of annual financial performance, often released before the full 10-K filing—is characteristic of an Earnings Release (ER) or a detailed Interim/Quarterly Report (IR). Since this covers the full fiscal year (Jan-Dec 2019) and provides extensive analysis, it aligns best with the comprehensive nature of an Interim/Quarterly Report (IR), although it serves the function of an annual summary. Given the options, 'IR' (Interim / Quarterly Report) is the closest fit for a detailed year-end financial summary that isn't the full 10-K or just a brief press release (ER). The document is substantial (over 63k characters) and contains detailed financial statements and management discussion, ruling out RPA/RNS. FY 2019
2020-02-05 Swedish
Earnings Release 2019
Earnings Release Classification · 1% confidence The document provides a detailed financial summary for the period ending December 31, 2019, including key performance indicators (Net sales, EBITDA, Profit/loss before tax) for both Q4 2019 and the Full year 2019, compared to the previous year. It includes a CEO's commentary, market development analysis, and specific financial tables. This structure, covering a full fiscal year and providing comprehensive financial details, strongly indicates an Annual Report or a document closely related to it, such as a detailed Interim/Quarterly Report (IR) or an Earnings Release (ER) that is unusually comprehensive. Since it covers the full year ('Year-end bulletin Jan-Dec 2019') and contains extensive financial breakdowns, it is more comprehensive than a typical Earnings Release (ER) which focuses on highlights. It is also more detailed than a standard Interim Report (IR) which usually covers half-years or quarters. Given the comprehensive nature covering the full fiscal year performance, it aligns best with the scope of an Annual Report (10-K), although it might be a pre-filing version or a detailed annual review. However, since it is not explicitly labeled as a 10-K filing and focuses heavily on the financial results narrative, the most appropriate classification among the provided options for a comprehensive annual financial review is the Annual Report (10-K) if it were a formal SEC filing, or the Interim Report (IR) if it's a comprehensive non-SEC annual review. Given the depth and the 'Full year' focus, and lacking explicit SEC headers, it functions as a comprehensive annual financial disclosure. In many contexts, a comprehensive annual financial report that is not the official 10-K filing is often categorized as a detailed Interim Report (IR) if it's not the 10-K itself. However, the content strongly suggests the full annual performance review. Since the document is very long (66k chars) and contains the full year's results, it is the report itself, not an announcement of a report (RPA/RNS). Between 10-K and IR, 10-K is reserved for the official SEC filing. This looks like a detailed annual financial statement release. I will classify it as an Interim Report (IR) as it covers the full year but might not be the final 10-K filing, or as 10-K if we assume this is the content of the annual filing. Given the context of 'Year-end bulletin' and detailed financials, 10-K is the closest fit for a full-year performance document, even if it's a preliminary version. Q4 2019
2020-02-05 English
CellaVision AB: Continued growth and acquisition of RAL Diagnostics
Interim / Quarterly Report Classification · 1% confidence The document is an interim financial report for CellaVision for the period ending September 30, 2019. It contains detailed financial statements, key ratios, management commentary, and operational updates. Although it includes a link to an attachment at the end, the text itself provides the substantive financial data and analysis required for an interim report, distinguishing it from a mere publication announcement. 9M 2019
2019-10-23 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-September 2019. It contains detailed financial statements (income statement, cash flow, balance sheet metrics), management commentary on business performance, regional market analysis, and operational updates. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2019
2019-10-23 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.